Skip to main content
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · CTXR ISIN · US17322U2078 LEI · 5493005C10W36P4KQP40 US Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2018-01-12 Transaction in Own Shar…
Country US United States of America
Listing US CTXR

About Citius Pharmaceuticals, Inc.

https://www.citiuspharma.com/

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).

Recent filings

Filing Released Lang Actions
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
Transaction in Own Shares Classification · 95% confidence The document is titled 'Post-Effective Amendment No. 1 to Form S-1' and is filed with the SEC. It references a registration statement on Form S-1, which is used for securities registration under the Securities Act of 1933. The document discusses updating the registration statement to include information from the company's annual report on Form 10-K and maintaining registration of shares underlying warrants. It is a post-effective amendment to a registration statement related to securities offerings, not a financial report or earnings release. The content is consistent with a capital/financing update or securities registration amendment. Therefore, the document fits best under the category 'Transaction in Own Shares' (POS), which includes share repurchase/issuance and related filings. The document is not a full financial report, earnings release, or proxy statement, but a post-effective amendment to a registration statement related to securities issuance.
2018-01-12 English
OWNERSHIP DOCUMENT
Director's Dealing
2018-01-08 English
Regulatory Filings 2017
Regulatory Filings
2017-12-20 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving the sale of common stock and warrants, details about the securities purchase agreements, placement agent engagement, and related financial terms. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The document focuses on a financing transaction and capital raising activity. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 8180 characters, which is sufficient for a detailed announcement rather than a brief notice or certification. Hence, the classification is CAP with high confidence.
2017-12-19 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a public offering of common stock and warrants by Citius Pharmaceuticals, Inc. It includes detailed information about the offering, pricing, use of proceeds, risk factors, and plan of distribution. The document is a registration and offering document used to raise capital through the sale of securities. It is not a financial report, earnings release, management discussion, or any other type of report. It is clearly a capital raising disclosure document, which fits the definition of a Capital/Financing Update (CAP).
2017-12-18 English
Regulatory Filings 2017
Regulatory Filings
2017-12-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.